Antithrombotic Effect of Geniposide and Genipin in the Mouse Thrombosis Model

 

 Buy Article Permissions and Reprints

Abstract

Geniposide is one of the constituents of Gardenia fruit (Gardenia jasminoides Ellis, Rubiaceae), which has been used in traditional medicine. Although its anti-inflammatory and antithrombotic effects have been reported, the way it acts is still unclear. We have investigated the effects of geniposide and its metabolite genipin on thrombogenesis and platelet aggregation. In an in vivo model, geniposide and genipin significantly (P < 0.05) prolonged the time required for thrombotic occlusion induced by photochemical reaction in the mouse femoral artery. In an in vitro study, both geniposide and genipin inhibited collagen-induced, but did not inhibit arachidonate-induced, mouse platelet aggregation. However aspirin, a cyclooxygenase inhibitor, inhibited arachidonate-induced platelet aggregation but only partially inhibited the collagen-induced one. We also showed, by measuring PLA₂-catalyzed arachidonic acid release, that geniposide inhibited phospholipase A₂ (PLA₂) activity. We conclude that geniposide showed an antithrombotic effect in vivo due to the suppression of platelet aggregation. PLA₂ inhibition by geniposide is one possible anti-platelet mechanism.

References

• 1 Ross R. The pathogenesis of atherosclerosis - an update.  New England Journal of Medicine. 1986;  314 488-500
  CrossrefPubMedGoogle Scholar
• 2 Fuster V, Badimon L, Cohen M, Ambrose J A, Badimon J J, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes.  Circulation. 1988;  77 1213-20
  CrossrefPubMedGoogle Scholar
• 3 Willerson J T, Golino P, Eidt J, Campbell W B, Buja L M. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.  Circulation. 1989;  80 198-205
  CrossrefPubMedGoogle Scholar
• 4 Sakuragawa N, Yuasa K, Niwa M, Kondo S. Studies on Wakan-yakus.  Acta Medica et Biologica. 1984;  32 107-13
  PubMedGoogle Scholar
• 5 Akao T, Kobayashi K, Aburada M. Enzymic studies on the animal and intestinal bacterial metabolism of geniposide.  Biol. Pharm. Bull.. 1994;  17 1573-6
  PubMedGoogle Scholar
• 6 Tanaka M, Kigawa M, Mitsuhashi H, Wakamatsu T. The practical method for the preparation of iridoid aglycons from their glycosides.  Heterocycles. 1991;  32 1451-4
  PubMedGoogle Scholar
• 7 Shimazawa M, Takiguchi Y, Umemura K, Kondo K, Nakashima M. Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022.  European Journal of Pharmacology. 1997;  328 183-9
  CrossrefPubMedGoogle Scholar
• 8 Kikuchi S, Umemura K, Kondo K, Saniabadi A R, Nakashima M. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening.  Arteriosclerosis, Thrombosis & Vascular Biology. 1998;  18 1069-78
  PubMedGoogle Scholar
• 9 Akagi K, Nagao T, Urushidani T. Calcium oscillations in single cultured Chinese hamster ovary cells stably transfected with a cloned human cholecystokinin (CCK)B receptor.  Japanese Journal of Pharmacology. 1997;  75 33-47
  PubMedGoogle Scholar
• 10 Martinez-Salgado C, Rodriguez-Barbero A, Rodriguez-Puyol D, Perez de Lema G, Lopez-Novoa J M. Involvement of phospholipase A₂ in gentamicin-induced rat mesangial cell activation.  American Journal of Physiology. 1997;  273 F60-6
  PubMedGoogle Scholar
• 11 Hirata Y, Takiguchi Y, Wada K, Matsuno H, Umemura K, Uematsu T et al. Roles of platelet-activating factor, thromboxane A₂, ADP and thrombin in thrombogenesis in the guinea pig.  European Journal of Pharmacology. 1993;  231 421-5
  CrossrefPubMedGoogle Scholar
• 12 Mellwig K P, Jakobs K H. Inhibition of platelet adenylate cyclase by ADP.  Thrombosis Research. 1980;  18 7-17
  CrossrefPubMedGoogle Scholar
• 13 Rink T J, Sage S O. Calcium signaling in human platelets.  Annual Review of Physiology. 1990;  52 431-49
  CrossrefPubMedGoogle Scholar
• 14 Rand M L, Perry D W, Packham M A, Gemmell C H, Yeo E L, Kinlough-Rathbone R L. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.  American Journal of Hematology. 1996;  52 288-94
  CrossrefPubMedGoogle Scholar
• 15 Packham M A, Bryant N L, Guccione M A, Kinlough-Rathbone R L, Mustard J F. Effect of the concentration of Ca²⁺ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.  Thrombosis & Haemostasis. 1989;  62 968-76
  PubMedGoogle Scholar
• 16 Jantzen H M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds E E, Conley P B. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.  Thrombosis & Haemostasis. 1999;  81 111-7
  PubMedGoogle Scholar

Y. Suzuki

Department of Pharmacology

Hamamatsu University School of Medicine

1-20-1 Handayama

Hamamatsu, 431-3192

Japan

Email: yapplel@hama-med.ac.jp

Fax: +81-53-435 2270

Phone: Tel.: +81-53-435 2271